Abiomed Inc (Abiomed) is a provider of temporary mechanical circulatory support devices to enhance the care of heart failure patients. The company offers heart support and recovery products in a wide range of clinical settings, which include Impella 2.5 catheter; Impella 5.0 catheter; Impella 5.5 catheter; Impella CP percutaneous catheter-based Impella device; Impella LD percutaneous micro heart pumps; Impella RP percutaneous catheter-based axial flow pump; and automated Impella controller designed to control and monitor catheter performance and display real time position information.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Abiomed conducts research to develop a broad portfolio of heart recovery products with focus on circulatory support care. The company obtained numerous patents and has patent applications covering Impella product-line. Its pipeline product portfolio consists of a number of new products at various stages of development. They integrate with the Impella technology platform including the Impella ECP (catheter for enhanced blood flow), Impella XR Sheath (low-profile sheath that simplifies the process of heart pump insertion) and Impella BTR devices (percutaneous micro heart pump with integrated motors and sensors).